FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:373-379 January 27, 2005 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author's clinical recommendations.

A 47-year-old woman with a history of breast cancer presents with confusion and dehydration. The serum calcium level is 18.0 mg per deciliter (4.5 mmol per liter). She has postural hypotension and low central venous pressure on examination of the jugular veins. The serum phosphorus level is 5.0 mg per deciliter (1.6 mmol per liter), the blood urea nitrogen level is 80.0 . . . [Full Text of this Article]

The Clinical Problem

Strategies and Evidence

Diagnosis

Therapeutic Considerations

General Supportive Measures

Saline Hydration and Calciuresis

Medications

Other Pharmacologic Agents

Dialysis

Areas of Uncertainty

Guidelines

Recommendations

Source Information

From the Division of Endocrinology, University of Pittsburgh School of Medicine, Pittsburgh.

Address reprint requests to Dr. Stewart at the Division of Endocrinology and Metabolism, BST E-1140, University of Pittsburgh School of Medicine, 200 Lothrop St., Pittsburgh, PA 15213, or at stewart@dom.pitt.edu.

This article has been cited by other articles:

• Ibrahim, T., Barbanti, F., Giorgio-Marrano, G., Mercatali, L., Ronconi, S., Vicini, C., Amadori, D. (2008). Osteonecrosis of the Jaw in Patients with Bone Metastases Treated with Bisphosphonates: A Retrospective Study. The Oncologist 13: 330-336 [Abstract] [Full Text]  
• Venkatraman, L, Kalangutkar, A, Russell, C F (2007). Primary hyperparathyroidism and metastatic carcinoma within parathyroid gland. J. Clin. Pathol. 60: 1058-1060 [Full Text]  
• Bamias, A., Kastritis, E., Bamia, C., Moulopoulos, L. A., Melakopoulos, I., Bozas, G., Koutsoukou, V., Gika, D., Anagnostopoulos, A., Papadimitriou, C., Terpos, E., Dimopoulos, M. A. (2005). Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors. JCO 23: 8580-8587 [Abstract] [Full Text]  
• Jacobs, T. P., Bilezikian, J. P. (2005). Rare Causes of Hypercalcemia. J. Clin. Endocrinol. Metab. 90: 6316-6322 [Abstract] [Full Text]  
• Seeman, E., Strewler, G. J. (2005). Clinical and Basic Research Papers - January 2005 Selections. IBMS BoneKEy 2: 1-6 [Full Text]